TP53 and ovarian carcinoma: Soussi [23] surveyed literature from 1979 through 1999 on anti-p53 AAbs in the sera of patients with various types of cancer and found 11 studies that examined anti-p53 AAbs in the sera of ovarian carcinoma patients.